Abstract
BackgroundTo monitor long-term outcomes of ocrelizumab treatment.ObjectiveTo evaluate safety and treatment outcomes of ocrelizumab in a community-based multiple sclerosis (MS) population.MethodsAdult patients with MS prescribed ocrelizumab were eligible. Chart reviews...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
